US20070232808A1 - Process for preparing heterocyclic derivatives - Google Patents
Process for preparing heterocyclic derivatives Download PDFInfo
- Publication number
- US20070232808A1 US20070232808A1 US11/693,757 US69375707A US2007232808A1 US 20070232808 A1 US20070232808 A1 US 20070232808A1 US 69375707 A US69375707 A US 69375707A US 2007232808 A1 US2007232808 A1 US 2007232808A1
- Authority
- US
- United States
- Prior art keywords
- alkyl
- compounds
- alkoxy
- group
- halo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 *C1C(C)=NN=C1S Chemical compound *C1C(C)=NN=C1S 0.000 description 10
- RUKHOZQIAWYJKS-UHFFFAOYSA-N CC1=C(C(=O)O)C=CC=N1.CC1=C(C2=NN=C(S)N2C)C=CC=N1 Chemical compound CC1=C(C(=O)O)C=CC=N1.CC1=C(C2=NN=C(S)N2C)C=CC=N1 RUKHOZQIAWYJKS-UHFFFAOYSA-N 0.000 description 1
- MGBARAHGQKREBO-UHFFFAOYSA-N CC1=C(C(=O)O)OC=N1.CC1=C(C2=NN=C(S)N2C)OC=N1 Chemical compound CC1=C(C(=O)O)OC=N1.CC1=C(C2=NN=C(S)N2C)OC=N1 MGBARAHGQKREBO-UHFFFAOYSA-N 0.000 description 1
- GAJQWWVAWUFQMQ-UHFFFAOYSA-N CC1=NC(C)=C(C(=O)O)O1.CC1=NC(C)=C(C2=NN=C(S)N2C)O1 Chemical compound CC1=NC(C)=C(C(=O)O)O1.CC1=NC(C)=C(C2=NN=C(S)N2C)O1 GAJQWWVAWUFQMQ-UHFFFAOYSA-N 0.000 description 1
- JSPHREWOJSVQKY-UHFFFAOYSA-N CC1=NC(C)=C(C(=O)O)S1.CC1=NC(C)=C(C2=NN=C(S)N2C)S1 Chemical compound CC1=NC(C)=C(C(=O)O)S1.CC1=NC(C)=C(C2=NN=C(S)N2C)S1 JSPHREWOJSVQKY-UHFFFAOYSA-N 0.000 description 1
- PAQZWJGSJMLPMG-UHFFFAOYSA-N CCCP1(=O)OP(=O)(CCC)OP(=O)(CCC)O1 Chemical compound CCCP1(=O)OP(=O)(CCC)OP(=O)(CCC)O1 PAQZWJGSJMLPMG-UHFFFAOYSA-N 0.000 description 1
- HHASZFKIYOSHEW-UHFFFAOYSA-N CN1C(S)=NN=C1C1=CN=NC=C1.O=C(O)C1=CN=NC=C1 Chemical compound CN1C(S)=NN=C1C1=CN=NC=C1.O=C(O)C1=CN=NC=C1 HHASZFKIYOSHEW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Definitions
- the present invention relates to a novel process, useful for preparing key intermediates in the synthesis of various compounds, among them compounds which are potent and specific antagonists of D3 receptors.
- the present invention relates to a novel process for preparing thiazole or triazole derivatives of formula (I)
- C1-C6 alkyl refers to a linear or branched alkyl group containing from 1 to 6 carbon atoms; examples of such groups include methyl, ethyl, propyl, isopropyl, n-butyl, isobutyl, tert butyl, pentyl or hexyl.
- halogen refers to a fluorine, chlorine, bromine or iodine atom.
- halo C1-C6 alkyl means an alkyl group having one or more carbon atoms and wherein at least one hydrogen atom is replaced with halogen such as for example a trifluoromethyl group and the like.
- C1-C6 thioalkyl may be a linear or a branched chain thioalkyl group, for example thiomethyl, thioethyl, thiopropyl, thioisopropyl, thiobutyl, thiosec-butyl, thiotert-butyl and the like.
- C2-C6 alkenyl defines straight or branched chain hydrocarbon radicals containing one or more double bond and having from 2 to 6 carbon atoms such as, for example, ethenyl, 2-propenyl, 3-butenyl, 2-butenyl, 2-pentenyl, 3-pentenyl, 3-methyl-2-butenyl or 3-hexenyl and the like.
- C1-C6 alkoxy group may be a linear or a branched chain alkoxy group, for example methoxy, ethoxy, propoxy, prop-2-oxy, butoxy, but-2-oxy or methylprop-2-oxy and the like.
- halo C1-C6 alkoxy group may be a C1-C6 alkoxy group as defined before substituted with at least one halogen, preferably fluorine, such as OCHF 2 , or OCF 3 .
- C2-C6 alkynyl defines straight or branched chain hydrocarbon radicals containing one or more triple bond and having from 2 to 6 carbon atoms including acetylenyl, propynyl, 1-butynyl, 1-pentynyl, 3-methyl-1-butynyl and the like.
- aryl means an aromatic carbocyclic moiety such as phenyl, biphenyl or naphthyl.
- heteroaryl means an aromatic heterocycle ring of 5 to 10 members and having at least one heteroatom selected from nitrogen, oxygen and sulfur, and containing at least 1 carbon atom, including both mono-and bicyclic ring systems.
- heteroaryls include (but are not limited to) furyl, benzofuranyl, thiophenyl, benzothiophenyl, pyrrolyl, indolyl, isoindolyl, azaindolyl, pyridyl, quinolinyl, isoquinolinyl, oxazolyl, isooxazolyl, benzoxazolyl, pyrazolyl, imidazolyl, benzimidazolyl, thiazolyl, benzothiazolyl, isothiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl, cinnolinyl, phthalazinyl, triazolyl, tetrazolyl, quinazolinyl, and benzodioxolyl.
- 5-6 membered heterocycle means, according to the above definition, a 5-6 monocyclic heterocyclic ring which is either saturated, unsaturated or aromatic, and which contains from 1 to 4 heteroatoms independently selected from nitrogen, oxygen and sulfur, and wherein the nitrogen and sulfur heteroatoms may be optionally oxidized, and the nitrogen heteroatom may be optionally quaternized.
- Heterocycles include heteroaryls as defined above. The heterocycle may be attached via any heteroatom or carbon atom.
- the term includes (but is not limited to) morpholinyl, pyridinyl, pyrazinyl, pyrazolyl, thiazolyl, triazolyl, imidazolyl, oxadiazolyl, oxazolyl, isoxazolyl, pyrrolidinonyl, pyrrolidinyl, piperidinyl, hydantoinyl, valerolactamyl, oxiranyl, oxetanyl, tetrahydrofuranyl, tetrahydropyranyl, tetrahydropyridinyl, tetrahydropyrimidinyl, tetrahydrothiophenyl, tetrahydrothiopyranyl, and the like.
- HOBt and its by-products have an explosive nature and DCC and its by-product are always difficult to fully remove.
- the process solves the above problems by using n-propane phosphonic cyclic anhydride, T3P, as condensation agent.
- T3P was first used in the peptide synthesis in 1980 by H. Wissmann (Angew. Chem., 1980, 92, 129) and is steadily gaining importance in organic synthesis because is less toxic and safer compared to other common condensation agents, such as DCC.
- T3P is used as 50% solution in ethyl acetate in the process of the present invention and does not need the isolation of the intermediate hydrazine-carbothiamide.
- T3P is available as 50% solution in DMF (dimethylformamide) and may be employed in the process of the present invention.
- the starting material, the heterocyclic carboxylic acid, generally commercially available or which may be prepared according to known methods in the literature, in an amount of 1 equivalent may be conveniently dissolved in the appropriate solvent (for example dimethylformamdide; ethyl acetate; acetonitrile and tetrahydrofurane and other polar aprotic solvent) and treated with a slightly excess of derivatives of 3-thiosemicarbazide (1.10 eq), such as 4-methyl derivative. Then an organic base (e.g. triethylamine, diisopropylethylamine and possibly other aliphatic of aromatic amines) is added at RT.
- the appropriate solvent for example dimethylformamdide; ethyl acetate; acetonitrile and tetrahydrofurane and other polar aprotic solvent
- derivatives of 3-thiosemicarbazide (1.10 eq)
- an organic base e.g. triethylamine
- N-propane phosphonic cyclic anhydride (50% w/w in ethyl acetate) may be then added at a temperature ranging from 0 to 40 degrees dropwise. In case the addition is made at about 0° C., the temperature is then maintained below 15° C. over 20-60 minutes. The resulting mixture was then stirred at 20° C. for 2-16 hours.
- the mixture is then diluted with an aqueous solution of an appropriate inorganic base until basic pH was reached.
- the suitable base may be selected among: potassium carbonate, sodium carbonate, sodium hydroxide, potassium hydroxide.
- the resulting bi-phasic mixture (when observed) is then allowed separating and the upper organic layer discarded.
- the aqueous layer is then heated to 50-90° C. (internal temperature) for half an hour to several hours until reaction completion.
- an appropriate mineral acid e.g. HCl 37%) is then slowly added to adjust the pH as needed. (4 to 8).
- the suspension is then generally stirred for 2-16 hours, then the solid was filtered, washed with pure water and dried in a vacuum oven at 40-60° C. until dryness.
- the final product is isolated from the aqueous mixture uncontaminated by phosphorous derivatives.
- Step 1 Time-Reserv.A-Reserv.B Time 0 min 100%
- Step 2 Time-Reserv.A-Reserv.B Time 8 min 5%
- Step 3 Time-Reserv.A-Reserv.B Time 8.01 min 100%
- the mixture was diluted with NaOH 4 M (120.0 mL). The resulting bi-phasic mixture was allowed separating and the upper organic layer discarded.
- the suspension was stirred for 8 hours, then the solid was filtered and washed with water (60 mL), and it was dried in a vacuum oven at 40° C. overnight.
- the suspension was cooled to 5° C. and the solid was filtered and washed with water, and it was then dried in a vacuum oven at 40° C. overnight.
- the solid was filtered and it was then dried in a vacuum oven at 40° C. overnight.
- the solid was filtered and washed with water (3 times with 20 mL), and it was then dried in a vacuum oven at 40° C. overnight.
- mixture was allowed to reach ambient temperature and stirred for 2 hours under nitrogen.
- the pH of the mixture was checked over time and pH adjusted to 12 if necessary. The heating was kept for a total amount of 3 hours.
- the mixture was filtered, the cake washed with 22.5 mL of water and the collected solid dried under vacuum oven at 40° C. for 5 hours.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/608,184 US7838680B2 (en) | 2006-04-03 | 2009-10-29 | Process for preparing heterocyclic derivatives |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0607899.2A GB0607899D0 (en) | 2006-04-03 | 2006-04-03 | Process for preparing heterocyclic derivatives |
| GB0607899.2 | 2006-04-03 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/608,184 Continuation US7838680B2 (en) | 2006-04-03 | 2009-10-29 | Process for preparing heterocyclic derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20070232808A1 true US20070232808A1 (en) | 2007-10-04 |
Family
ID=36581002
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/693,757 Abandoned US20070232808A1 (en) | 2006-04-03 | 2007-03-30 | Process for preparing heterocyclic derivatives |
| US12/608,184 Expired - Fee Related US7838680B2 (en) | 2006-04-03 | 2009-10-29 | Process for preparing heterocyclic derivatives |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/608,184 Expired - Fee Related US7838680B2 (en) | 2006-04-03 | 2009-10-29 | Process for preparing heterocyclic derivatives |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20070232808A1 (https=) |
| EP (1) | EP2007747B1 (https=) |
| JP (1) | JP5167242B2 (https=) |
| KR (1) | KR101411124B1 (https=) |
| CN (1) | CN101454308B (https=) |
| AU (1) | AU2007233744B2 (https=) |
| BR (1) | BRPI0710049A2 (https=) |
| CA (1) | CA2648089A1 (https=) |
| CR (1) | CR10351A (https=) |
| EA (1) | EA017304B1 (https=) |
| ES (1) | ES2443219T3 (https=) |
| GB (1) | GB0607899D0 (https=) |
| IL (1) | IL194389A0 (https=) |
| MA (1) | MA30354B1 (https=) |
| MX (1) | MX2008012876A (https=) |
| NO (1) | NO20084414L (https=) |
| WO (1) | WO2007113261A1 (https=) |
| ZA (1) | ZA200808107B (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018189340A1 (en) | 2017-04-14 | 2018-10-18 | Italfarmaco S.P.A. | Selective hdac6 inhibitors |
| WO2022029041A1 (en) | 2020-08-07 | 2022-02-10 | Italfarmaco S.P.A. | 2-(4-((5-(benzo[b]thiophen-3-yl)-1h-tetrazol-1-yl)methyl)phenyl)-5-(difluoromethyl)-1,3,4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (hdac6) for use in treating e.g. peripheral neuropathy |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3995C2 (ro) * | 2009-05-11 | 2010-07-31 | Государственный Университет Молд0 | Utilizare a di(µ-Ofenoxi)-di{[2-(4-aminobenzensulfamido)-5-etil-1,3,4-tiadiazol]-3,5-dibromosalicilidentiosemicarbazonato(-1)-cupru} în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar |
| CN106866657A (zh) * | 2017-04-25 | 2017-06-20 | 成都倍特药业有限公司 | 一种麦角新碱的制备方法 |
| US9862675B1 (en) | 2017-07-05 | 2018-01-09 | King Fahd University Of Petroleum And Minerals | Method of N-formylating amines with a phosphonic anhydride |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020032238A1 (en) * | 2000-07-08 | 2002-03-14 | Henning Priepke | Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10033337A1 (de) * | 2000-07-08 | 2002-01-17 | Boehringer Ingelheim Pharma | Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
| WO2002032238A2 (de) * | 2000-10-20 | 2002-04-25 | Messmer, Ludwig | Hochverdichteter filter tow ballen |
| PE20051173A1 (es) * | 2004-02-23 | 2006-02-14 | Glaxo Group Ltd | Compuestos azabiciclico (3.1.0) hexanos como moduladores de receptores de dopamina d3 |
| GB0517193D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Novel use |
-
2006
- 2006-04-03 GB GBGB0607899.2A patent/GB0607899D0/en not_active Ceased
-
2007
- 2007-03-30 CN CN200780019578XA patent/CN101454308B/zh not_active Expired - Fee Related
- 2007-03-30 CA CA002648089A patent/CA2648089A1/en not_active Abandoned
- 2007-03-30 AU AU2007233744A patent/AU2007233744B2/en not_active Ceased
- 2007-03-30 KR KR1020087026730A patent/KR101411124B1/ko not_active Expired - Fee Related
- 2007-03-30 JP JP2009503555A patent/JP5167242B2/ja not_active Expired - Fee Related
- 2007-03-30 EP EP07727590.7A patent/EP2007747B1/en active Active
- 2007-03-30 BR BRPI0710049-3A patent/BRPI0710049A2/pt not_active Application Discontinuation
- 2007-03-30 US US11/693,757 patent/US20070232808A1/en not_active Abandoned
- 2007-03-30 ES ES07727590.7T patent/ES2443219T3/es active Active
- 2007-03-30 EA EA200870405A patent/EA017304B1/ru not_active IP Right Cessation
- 2007-03-30 WO PCT/EP2007/053118 patent/WO2007113261A1/en not_active Ceased
- 2007-03-30 MX MX2008012876A patent/MX2008012876A/es active IP Right Grant
-
2008
- 2008-09-22 ZA ZA200808107A patent/ZA200808107B/xx unknown
- 2008-09-25 IL IL194389A patent/IL194389A0/en unknown
- 2008-10-07 CR CR10351A patent/CR10351A/es unknown
- 2008-10-21 NO NO20084414A patent/NO20084414L/no not_active Application Discontinuation
- 2008-10-23 MA MA31326A patent/MA30354B1/fr unknown
-
2009
- 2009-10-29 US US12/608,184 patent/US7838680B2/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020032238A1 (en) * | 2000-07-08 | 2002-03-14 | Henning Priepke | Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018189340A1 (en) | 2017-04-14 | 2018-10-18 | Italfarmaco S.P.A. | Selective hdac6 inhibitors |
| US11351178B2 (en) | 2017-04-14 | 2022-06-07 | Italfarmaco Spa | Selective HDAC6 inhibitors |
| WO2022029041A1 (en) | 2020-08-07 | 2022-02-10 | Italfarmaco S.P.A. | 2-(4-((5-(benzo[b]thiophen-3-yl)-1h-tetrazol-1-yl)methyl)phenyl)-5-(difluoromethyl)-1,3,4-oxadiazole derivatives and similar compounds as selective inhibitors of histone deacetylase 6 (hdac6) for use in treating e.g. peripheral neuropathy |
Also Published As
| Publication number | Publication date |
|---|---|
| US20100048895A1 (en) | 2010-02-25 |
| ZA200808107B (en) | 2009-10-28 |
| JP5167242B2 (ja) | 2013-03-21 |
| CN101454308B (zh) | 2013-05-08 |
| IL194389A0 (en) | 2009-08-03 |
| EP2007747A1 (en) | 2008-12-31 |
| CR10351A (es) | 2008-10-29 |
| EA200870405A1 (ru) | 2009-04-28 |
| EA017304B1 (ru) | 2012-11-30 |
| KR20080108328A (ko) | 2008-12-12 |
| AU2007233744B2 (en) | 2012-09-06 |
| AU2007233744A1 (en) | 2007-10-11 |
| CN101454308A (zh) | 2009-06-10 |
| NO20084414L (no) | 2008-10-28 |
| WO2007113261A1 (en) | 2007-10-11 |
| GB0607899D0 (en) | 2006-05-31 |
| BRPI0710049A2 (pt) | 2011-08-02 |
| ES2443219T3 (es) | 2014-02-18 |
| EP2007747B1 (en) | 2013-11-20 |
| MA30354B1 (fr) | 2009-04-01 |
| CA2648089A1 (en) | 2007-10-11 |
| KR101411124B1 (ko) | 2014-06-25 |
| US7838680B2 (en) | 2010-11-23 |
| JP2009532428A (ja) | 2009-09-10 |
| MX2008012876A (es) | 2008-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2476430C2 (ru) | Производные аминодигидротиазина, замещенные циклической группой | |
| EP2602260B1 (en) | Process for preparing compound having hiv integrase inhibitory activity | |
| JP6618120B2 (ja) | TrkA阻害活性を有する複素環および炭素環誘導体 | |
| AU2023368731A1 (en) | Nitrogen-containing fused ring compound, intermediate thereof, preparation method therefor and use thereof | |
| CN110997644A (zh) | 取代的3-芳基-5-三氟甲基-1,2,4-噁二唑类的制备 | |
| AU2013255437A1 (en) | Substituted pyridine compounds as CRAC modulators | |
| WO2007082131A1 (en) | Process for the preparation of hydroxy substituted heterocycles | |
| US7838680B2 (en) | Process for preparing heterocyclic derivatives | |
| KR20120104241A (ko) | Mk2 억제제 | |
| WO2015147247A1 (ja) | Hiv複製阻害作用を有する3環性誘導体 | |
| WO2016098793A1 (ja) | 環状グアニジル基を有するチアゾール誘導体 | |
| KR102946998B1 (ko) | 치환된 3-아릴-5-트리플루오로메틸-1,2,4-옥사디아졸의 제조 | |
| CN117751113A (zh) | 芳香乙炔类衍生物及其制备方法和用途 | |
| WO2013050341A1 (en) | Azabenzoxazine derivatives as crac modulators | |
| JP2014080395A (ja) | アミノラクタム誘導体およびそれらを含有する医薬組成物 | |
| Maiti et al. | A One-Pot Synthesis of the 1-Benzopyrano [2, 3-b] pyridine Moiety from 2-(Alkyl/Arylamino)-4-oxo-4H-1-benzopyran-3-carbaldehyde. | |
| US12247014B2 (en) | 2,3-diaryl-1,3-thiazepan-4-ones compounds and methods for making | |
| CN111032654A (zh) | 用于疗法的双环杂芳族脲或氨基甲酸酯化合物 | |
| WO2025241048A1 (en) | Inhibitors of lactate dehydrogenase, compositions comprising the inhibitor, and methods of use thereof | |
| US20230357155A1 (en) | Improved synthesis of 4-amino-6-(heterocyclic)picolinates | |
| KR20080002937A (ko) | 비시클릭 화합물의 제조 방법 | |
| HK1180676B (en) | Process for preparing compound having hiv integrase inhibitory activity | |
| BR112019015231A2 (pt) | processos para a preparação de compostos e compostos | |
| HK1229321A1 (en) | Process for preparing compound having hiv integrase inhibitory activity | |
| HK1180676A (en) | Process for preparing compound having hiv integrase inhibitory activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: GLAXO GROUP LIMITED, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BACCHI, SERGIO;REEL/FRAME:019261/0642 Effective date: 20070503 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE |
|
| AS | Assignment |
Owner name: GLAXO GROUP LIMITED, UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BACCHI, SERGIO;REEL/FRAME:024778/0806 Effective date: 20070503 |